Pfizer, Gilead-Yuhan and more—FiercePharmaAsia by Angus Liu Friday, January 11, 2019 Pfizer closes two Hospira plants in India; Gilead licenses Yuhan's NASH programs; Fujifilm is expanding its footprint in the U.S.
FiercePharmaAsia—Pfizer, China-India alliance, Sinovant and more by Angus Liu Friday, July 20, 2018 Pfizer halts production at a legacy Hospira plant; China works to offer Indian drugmakers streamlined access; Roivant's Sinovant debuts with 11 assets.
